IMNM
Income statement / Annual
Last year (2023), Immunome, Inc.'s total revenue was $14.02 M,
and the percentage change from the previous year is not available.
In 2023, Immunome, Inc.'s net income was -$106.81 M.
See Immunome, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$14.02 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$22.93 M
|
$631,000.00
|
$755,000.00
|
$755,000.00
|
$615,000.00
|
$521,000.00
|
| Gross Profit |
-$8.91 M
|
-$631,000.00
|
-$755,000.00
|
-$755,000.00
|
-$615,000.00
|
-$521,000.00
|
| Gross Profit Ratio |
-0.64
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$103.16 M
|
$23.27 M
|
$14.11 M
|
$7.49 M
|
$8.82 M
|
$6.88 M
|
| General & Administrative Expenses |
$19.66 M
|
$13.63 M
|
$11.09 M
|
$4.78 M
|
$1.53 M
|
$866,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$19.66 M
|
$13.63 M
|
$11.09 M
|
$4.78 M
|
$1.53 M
|
$866,000.00
|
| Other Expenses |
$0.00
|
$0.00
|
$503,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$122.82 M
|
$36.90 M
|
$25.20 M
|
$12.26 M
|
$10.35 M
|
$7.74 M
|
| Cost And Expenses |
$123.55 M
|
$36.90 M
|
$25.20 M
|
$12.26 M
|
$10.35 M
|
$7.74 M
|
| Interest Income |
$2.72 M
|
$5,000.00
|
$10,000.00
|
$1,000.00
|
$10,000.00
|
$39,000.00
|
| Interest Expense |
$0.00
|
$5,000.00
|
$10,000.00
|
$38,000.00
|
$106,000.00
|
$141,000.00
|
| Depreciation & Amortization |
$728,000.00
|
$631,000.00
|
$755,000.00
|
$755,000.00
|
$615,000.00
|
$521,000.00
|
| EBITDA |
-$28.27 M |
-$36.27 M |
-$23.95 M |
-$17.04 M |
-$9.72 M |
-$7.18 M |
| EBITDA Ratio |
-2.02
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-7.81
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.72 M
|
$5,000.00
|
$493,000.00
|
-$5.58 M
|
-$96,000.00
|
-$102,000.00
|
| Income Before Tax |
-$106.81 M
|
-$36.90 M
|
-$24.71 M
|
-$17.84 M
|
-$10.44 M
|
-$7.85 M
|
| Income Before Tax Ratio |
-7.62
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$617,000.00
|
-$242,000.00
|
-$717,000.00
|
$106,000.00
|
$39,000.00
|
| Net Income |
-$106.81 M
|
-$37.51 M
|
-$24.47 M
|
-$17.12 M
|
-$10.55 M
|
-$7.85 M
|
| Net Income Ratio |
-7.62
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-5.38 |
-3.09 |
-2.12 |
-1.69 |
-1.84 |
-7.18 |
| EPS Diluted |
-5.38 |
-3.09 |
-2.12 |
-1.69 |
-1.84 |
-7.18 |
| Weighted Average Shares Out |
$19.84 M
|
$12.13 M
|
$11.54 M
|
$10.11 M
|
$5.74 M
|
$1.09 M
|
| Weighted Average Shares Out Diluted |
$19.84 M
|
$12.13 M
|
$11.54 M
|
$10.11 M
|
$5.74 M
|
$1.09 M
|
| Link |
|
|
|
|
|
|
